Liddle Syndrome 1; Lidls1

Table of contents:

Description
Related genes
Clinical Features
Incidence and onset information
Alternative Names
Researches and researchers
Gene Panels
Sources and references

Description

Liddle syndrome is an autosomal dominant disorder characterized by early-onset salt-sensitive hypertension, hypokalemia, metabolic alkalosis, and suppression of plasma renin activity and aldosterone secretion (summary by Yang et al., 2014). Genetic Heterogeneity of Liddle SyndromeLiddle syndrome-2 (OMIM ) is caused by mutation in the SCNN1G gene (OMIM ), which encodes the ENaC gamma subunit. Liddle syndrome-3 (OMIM ) is caused by mutation in the SCNN1A gene (OMIM ), which encodes the ENaC alpha subunit.Hanukoglu and Hanukoglu (2016) provided a detailed review of the ENaC gene family, including structure, function, tissue distribution, and associated inherited diseases.

Genes related to Liddle Syndrome 1; Lidls1

SCNN1B

View recommended genes panels

Clinical Features

Top most frequent phenotypes and symptoms related to Liddle Syndrome 1; Lidls1

Hypertension
Renal insufficiency
Stroke
Stage 5 chronic kidney disease
Abnormality of the cardiovascular system
Myocardial infarction
Hypokalemia
Hyperaldosteronism
Alkalosis
Metabolic alkalosis

And another 6 symptoms. If you need more information about this disease we can help you.

Click here to know more about Mendelian.

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
— No data available about the known clinical features onset.

Alternative names

Liddle Syndrome 1; Lidls1 Is also known as lidls, liddle syndrome, pseudoaldosteronism, pseudohyperaldosteronism.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Liddle Syndrome 1; Lidls1 Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Pseudohypoaldosteronism Type 1 Evaluation (SCNN1A, SCNN1B, SCNN1G). By Athena Diagnostics Inc (United States). SCNN1A, SCNN1B, SCNN1G Specificity 34 % Genes 100 %
SCNN1B DNA Sequencing Test. By Athena Diagnostics Inc (United States). SCNN1B Specificity 100 % Genes 100 %
Monogenic Hypertension Evaluation. By Athena Diagnostics Inc (United States). SCNN1B, SCNN1G, CYP11B1, HSD11B2 Specificity 25 % Genes 100 %
Liddle's Syndrome Evaluation. By Athena Diagnostics Inc (United States). SCNN1B, SCNN1G Specificity 50 % Genes 100 %
Comprehensive Pulmonary Panel. By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States). RPGR, SCNN1A, SCNN1B, SCNN1G, BMPR1B, BMPR2, SFTPA1, SFTPA2, SFTPB, SFTPC, SFTPD, SLC7A7, SPAG1, STAT3, TERC, TERT, TINF2, NKX2-1, TSC1, TSC2 , (...) View the complete list with 73 more genes Panel complete gene list RPGR, SCNN1A, SCNN1B, SCNN1G, BMPR1B, BMPR2, SFTPA1, SFTPA2, SFTPB, SFTPC, SFTPD, SLC7A7, SPAG1, STAT3, TERC, TERT, TINF2, NKX2-1, TSC1, TSC2, RSPH1, CFAP298, CAV1, HPS3, HPS4, RTEL1, NME8, LRRC6, HPS5, DTNBP1, ACVRL1, INVS, CENPF, CCNO, DNAI2, HPS6, CFTR, DOCK8, ZMYND10, DNAAF2, BLOC1S3, RSPH3, RSPH9, DNAAF4, RSPH4A, DNAL1, DRC1, CSF2RA, CSF2RB, CCDC39, TTC25, ARMC4, OFD1, DNAAF5, CCDC40, CCDC114, FLCN, ELMOD2, CCDC151, DKC1, DNAH1, DNAH11, DNAH5, DNAH8, DNAI1, CCDC65, DNAAF3, DNAAF1, DNAJB13, EDN3, EFEMP2, CCDC103, ABCA3, ELN, ENG, FBLN5, FOXF1, MCIDAS, GAS8, GDF2, ALMS1, HPS1, AP3B1, KCNA5, KCNK3, LTBP4, SMAD4, SMAD9, MUC5B, BLOC1S6, PARN, SERPINA1, PHOX2B Specificity 2 % Genes 100 %
Primary Ciliary Dyskinesia and Cystic Fibrosis Panel. By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States). RPGR, SCNN1A, SCNN1B, SCNN1G, SPAG1, RSPH1, CFAP298, NME8, LRRC6, INVS, CENPF, CCNO, DNAI2, CFTR, ZMYND10, DNAAF2, RSPH3, RSPH9, DNAAF4, RSPH4A , (...) View the complete list with 22 more genes Panel complete gene list RPGR, SCNN1A, SCNN1B, SCNN1G, SPAG1, RSPH1, CFAP298, NME8, LRRC6, INVS, CENPF, CCNO, DNAI2, CFTR, ZMYND10, DNAAF2, RSPH3, RSPH9, DNAAF4, RSPH4A, DNAL1, DRC1, CCDC39, TTC25, ARMC4, OFD1, DNAAF5, CCDC40, CCDC114, CCDC151, DNAH1, DNAH11, DNAH5, DNAH8, DNAI1, CCDC65, DNAAF3, DNAAF1, DNAJB13, CCDC103, MCIDAS, GAS8 Specificity 3 % Genes 100 %
Cystic Fibrosis and CF-Related Disorders NGS Panel. By Johns Hopkins DNA Diagnostic Laboratory Johns Hopkins Hospital (United States). SCNN1A, SCNN1B, SCNN1G, CA12, CFTR Specificity 20 % Genes 100 %
Cystic Fibrosis Related Disorders NGS Panel. By Johns Hopkins DNA Diagnostic Laboratory Johns Hopkins Hospital (United States). SCNN1A, SCNN1B, SCNN1G, CA12 Specificity 25 % Genes 100 %

You can get up to 55 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM Genetic Syndrome Finder

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2 ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3